Suramin
 | This article is a stub. |
Suramin or suramin sodium is an antiparasitic drug normally used to treat an African neurological diaease often known as African trypanosomiasis or "Sleeping Sickness".[1] African trypanosomiasis is caused by the trypanosoma brucei parasite, and control effects reduced cases to around 2,000 per year by 2019.[1]
Side effects[edit | edit source]
Availability[edit | edit source]
Suramin is not commercially available in the United States or Canada.[2][1]
Evidence[edit | edit source]
Suramin is known to be effective for African trypanosomiasis.[1][2]
ME/CFS[edit | edit source]
Surami is being investigated as a treatment for ME/CFS.[3]
Learn more[edit | edit source]
- Suramin Sodium - drugs.com
- Deep Dive into the Science on ME - Open Medicine Foundation
See also[edit | edit source]
References[edit | edit source]
- ↑ 1.01.11.21.3 Centers for Disease Control (March 9, 2020). "African Trypanosomiasis". Centers for Disease Control. Retrieved September 26, 2020.
- ↑ 2.02.1 "Suramin Sodium Drug Information, Professional". Drugs.com. Retrieved April 30, 2019.
- ↑ Open Medicine Foundation (September 5, 2017). "Deep Dive Into The Science On ME". Open Medicine Foundation. Retrieved April 30, 2019.
adverse reaction Any unintended or unwanted response to a treatment, whether in a clinical trial or licensed treatment. May be minor or serious.
The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.
